Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1997-05-02
2000-08-29
LeGuyader, John L.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 435 911, 435325, 435354, 435455, 536 231, 536 2431, 536 2433, 536 245, 514 44, C07H 2104, C12Q 168, C12N 1500, A61K 4800
Patent
active
061107425
ABSTRACT:
A synthetic nuclease resistant antisense oligodeoxynucleotide (AS-OND) capable of selectively modulating human acetylcholinesterase production in the central nervous system is provided. In an embodiment the antisense oligodeoxynucleotide can be selected from
REFERENCES:
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-01-01), Frossard
patent: 5192659 (1993-03-01), Simons
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5455044 (1995-10-01), Kim et al.
patent: 5558852 (1996-09-01), Bigner et al.
Branch TIBS 23:45-50 Feb. 1998.
Agrawal et al., 1991. Pharmacokinetics, biodistribution, and stability of igodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA, 88:7595.
Agrawal, 1996. Antisense oligonucleotides: towards clinical trials, Tibtech, 14:376.
Beeri et al., 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Current Biology, 5:1063-1071.
Ben Aziz-Aloya et al., 1993. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos, Proc. Natl. Acad. Sci. USA, 90:2471-2475.
Betz et al., 1994, Basic Neurochem. Molecular Cell, (Raven Press Ltd, NY) 5th Ed., 681-699.
Birikh et al, 1997. Probing Accessible Sites for Ribozymes on Human Acetylcholinesterase RNA, RNA Apr., 1997 pp. 429-437.
Brem et al., 1993. Polymers as controlled drug delivery devised for the treatment of malignant brain tumors, Eur. J. Pharm. Biopharm 39:2-7.
Bickel, et al., 1993. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery, Proc. Natl. Acad. Sci. USA 90(7)2618-2622.
Calabretta, et al, 1996. Antisense strategies in the treatment of leukemias, Semin. Oncol., 23:78.
Crooke, 1995. Progress in antisense therapeutics, Hematol. Pathol., 2:59. [*n/a--will mail in].
Darboux, et al., 1996. The structure-function relationships in Drosophila neurotactin shows that cholinesterasic domains may have adhesive properties, EMBRO J., 15:4835-4843.
Ehrlich et al., 1994. Use of partially phosphorothioated "Antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis. Antisense Res. Develop., 4:173-183.
Galileo et al., 1991. J. Cell. Biol., 112:1285. [*n/a--will mail in].
Gewirtz, 1993. Oligodeoxynucleotide-based therapeutics for human leukemias, Stem Cells Dayt., 11:96.
Grifman et al., 1995. Impairment of neurite extension and apoptosis-dependent DNA fragmentation in primary neuronal cell cultures administered with an ACHE antisense oligonucleotide (Abstract) J. Neurochem., 65 (supplement) S82D.
Grifman et al., 1997. Potential antisense oligonucleotide therapies for neurodegenerative diseases. In Concepts in Gene Therapy, M. Strauss and J.A. Barranger, eds. (Walter de Gruyter & Co., Berlin).
Hanania, et al 1995. Recent advances in the application of gene therapy to human disease, Am. J. Med., 99:537.
Jones et al., 1995. The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture of rat midbrain, Cell Tissue Res., 2679:323-330.
Karpel et al. 1994. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins, Exptl. Cell. Res. 210:268-277.
Karpel et al, 1996. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells, J. Neurochem. 66:114-123.
Knapp et al., 1994. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA, 271:985-991.
Lapidot-Lifson, et al, 1992. Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis, Proc. Natl. Acad. Sci. USA, 89:579.
Layer, 1995. Non-classical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease, Alzheimer Disease adn associated disorders, 9:29.
Lefebvre-D'Hellencourt, et al, 1995. Immunomodulation by cytokine antisense oligonucleotides, Eur. Cytokine Netw., 6:7. [*n/a--will mail in].
Legay et al. 1993a. Cloning and expression of a rat acetylcholinesterase subunit: generation of multiple molecular forms, complementarity with a Torpedo collagenic subunit, J. Neurochem. 60:337-346.
Legay et al. 1993b. Expression of a cDNA encoding the glycolipid-anchored form of rat acetylcholinesterase, FEBS Lett 315:163-166.
Lev-Lehman et al., 1994. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Therapy, 1:127-135.
Lev-Lehman et al., 1997. Antisense Oligomers in vitro and in vivo. In Antisense Therapeutics, A. Cohen and S. Smicek, eds (Plenum Press, New York).
Li et al., 1991. Gene structure of mammalian acetylcholinesterase: Alternative exons dictate tissue specific expression, J. Biol. Chem. 266:23083-23090.
Li et al., 1993. Tissue-specific Expression and Alternative mRNA Processing of the Mammalian Acetylcholinesterase Gene, J. Biol. Chem. 268:5790-97.
Morrison, R. 1992. Neuroscience Facts 3:3. [*n/a--will mail in].
Pardridge, et al., 1992. Blood-brain barrier and new approaches to brain drug delivery. West J. Med. 156(3):281-286.
Pardridge, 1992. Recent Developments in peptide drug delivery to the brain, Pharm. Toxicol. 71(1):3-10.
Patinkin, et al., 1994. Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors, Cell. Mol. Neurobiol., 14:459.
Rosolen et al., 1990. Antisense Inhibition of Single Copy N-myc Expression Results in Decreased Cell Growth without Reduction of c-myc Protein in a Neuroepittelioma Cell Line, Cancer Res., 50:6316.
Scanlon, et al., 1995. Oligonucleotides-mediated modulation of mammalian gene expression, FASEB J., 9:1288.
Small, et al., 1995. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture, J. Neurosci., 15:144-151.
Soreq, et al., 1994. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo, Proc. Natl. Acad. Sci. USA, 91:7907-7911.
Stein and Cheng, 1993. Antisense oligonucleotides as therapeutic agents--Is the bullet really magical? Science, 261:1004.
Sternfield, et al., 1997. Catalytic and non-catalytic acetylcholinesterase functions implied from transgenic ACHE expression in vertebrates. In Neurotransmitter Release and Uptake, S. Pogun ed. (Springer-Verlag, Berlin).
Wagner, 1994. Gene inhibition using antisense oligodeoxynucleotides, Nature, 372:333.
Winstein et al., 1991. J. Cell Biol., 112:1205. [*n/a--will mail in].
Chalazonitis, A., Kessler JA, Twardzik DR, Morrison RS, 1992. Neuroscience Facts 3:3. (Originally cited under Morrison, J. Abstract only submitted at this time. Full article to follow).
Crooke, 1995. Progress in antisense therapeutics, Hematol. Pathol., 2:59.
Galileo et al., 1992. Retrovirally Introduced Antisense Integrin RNA Inhibits Neuroblast Migration In Vivo J. Cell. Biol., 112:1285. (Originally improperly cited as 1991).
Lefebvre-D'Hellencourt, et al, 1995. Immunomodulation by cytokine antisense oligonucleotides, Eur. Cytokine Netw., 6:7.
Winstein et al., 1991. J. Cell. Biol., 112:1205. (Will submit when available).
Eckstein Fritz
Seidman Shlomo
Soreq Hermona
Lacourciere Karen A
LeGuyader John L.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Synthetic antisense oligodeoxynucleotides targeted to AChE does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic antisense oligodeoxynucleotides targeted to AChE, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic antisense oligodeoxynucleotides targeted to AChE will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248881